Answers are grounded in this paper and cite their sources.
We performed a double-blind randomized placebo-controlled pilot study to determine the efficacy of tegaserod (Zelnorm) in treating constipation in 15 patients with Parkinson's disease (PD). There was a trend for improvement in the Subject's Global Assessment (SGA) of satisfaction with bowel habits (NS) and the total SGA (including abdominal discomfort, bothersome constipation, and satisfaction; NS).
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: